- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 29.11.24 | University of Birmingham identifies target to reduce GVHD risk | ||
| 29.11.24 | UK Government to launch first ever men's health strategy | ||
| 29.11.24 | UK reports near eradication of meningitis C amid declining vaccine uptake | ||
| 29.11.24 | CPI's Medicines Manufacturing Innovation Centre takes delivery of PACE Just in Time (JIT) Clinical Trials Drug Dispensing System | ||
| 29.11.24 | Allink Biotherapeutics secures funding to advance ADC pipeline | ||
| 29.11.24 | Formosa and Medvisis agree on post-operative eye pain therapy | ||
| 28.11.24 | Trump 2.0 spells global change in pharmaceutical regulation, funding and investment | ||
| 28.11.24 | Advanz Pharma's liver disease drug pulled from European market after court hearing | ||
| 28.11.24 | Kronos Bio announces interim CEO and workforce cuts of 83% | ||
| 28.11.24 | Trump agency nominations show pharma industry as divided as US | ||
| 28.11.24 | Health Canada approves Novo Nordisk's Wegovy to cut heart attacks | ||
| 28.11.24 | Combatting Infectious Disease: Challenges and Opportunities for Pharma in the Green Transition | ||
| 28.11.24 | CervoMed's stock rises as FDA grants orphan drug status to dementia drug | ||
| 28.11.24 | Wait for galactosemia therapy goes on after FDA shuns Applied Therapeutics' govorestat | ||
| 28.11.24 | EC approves GSK's Menveo vaccine presentation for IMD | ||
| 27.11.24 | Airways unbound: The biologic revolution in asthma treatment | ||
| 27.11.24 | BeiGene's PD-1 drug approved in EU for first-line oesophageal cancer treatment | ||
| 27.11.24 | The race for approval: oral GLP-1R therapies in obesity | ||
| 27.11.24 | Outlook Therapeutics stock craters as the wet AMD drug fails Phase III trial | ||
| 27.11.24 | Digital transformation expected to shorten drug development timelines | ||
| 27.11.24 | EC approves Novartis' Kisqali to treat early breast cancer | ||
| 27.11.24 | FDA approves Medtronic InPen app, launching Smart MDI system with Simplera CGM | ||
| 27.11.24 | Idorsia plans further job cuts and asset sale in latest cost-saving measures | ||
| 27.11.24 | FDA delays decision of Soleno's Prader-Willi syndrome drug | ||
| 27.11.24 | Acadia signs agreement with Saniona to commercialise SAN711 |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
